Duloxetine for the management of diabetic peripheral neuropathic pain: response profile (Q39332427)

11 September 2017

Duloxetine for the management of diabetic peripheral neuropathic pain: response profile (English)

1 reference

11 September 2017

0 references

0 references

Yili L Pritchett

1

1 reference

11 September 2017

Bill H McCarberg

series ordinal

2

1 reference

11 September 2017

John G Watkin

series ordinal

3

1 reference

11 September 2017

Michael J Robinson

series ordinal

4

1 reference

11 September 2017

1 July 2007

1 reference

11 September 2017

1 reference

11 September 2017

8

1 reference

11 September 2017

5

1 reference

11 September 2017

397-409

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

11 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

ABC of arterial and venous disease: vascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Diabetic somatic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Prevention and treatment of the complications of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Painful sensory polyneuropathy associated with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

The pathogenesis and management of painful diabetic neuropathy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Neurotransmitters in Nociceptive Modulatory Circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Duloxetine vs. placebo in patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Defining the clinically important difference in pain outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Memory for pain: relation between past and present pain intensity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

Patient compliance with paper and electronic diaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00305.X

10.1111/J.1526-4637.2007.00305.X

21 January 2018

Identifiers

DOI

1 reference

release_cf3oxwnfjzfybh27tbojs3n7cq

11 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cf3oxwnfjzfybh27tbojs3n7cq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference